key: cord-1010491-j8u1grdv
authors: Hossain, Rubayet; Ayub, Salman; Tarabichi, Yasir
title: Monocyte distribution width adds prognostic value in detection of COVID‐19 respiratory failure
date: 2021-09-29
journal: Int J Lab Hematol
DOI: 10.1111/ijlh.13712
sha: c7edd4e04105d3371cd4f5f7cd3e19312d8dd5f0
doc_id: 1010491
cord_uid: j8u1grdv

nan

The coronavirus disease 2019 (COVID-19) pandemic has stressed the resource-limited healthcare systems to a breaking point. 1, 2 In light of limited intensive care unit bed capacity, the ability to determine that patients require a higher level of care for COVID-19 induced hypoxemic respiratory failure (RF) is critical. 3 Several risk scoring systems have been proposed as a result. 4, 5 Many rely on routinely obtained laboratory data from cell count and population analyzers, with neutrophil-to-lymphocyte ratio (NLR) emerging as a leading predictor of COVID-19 disease severity. 6 The monocyte distribution width (MDW), another potential product of cell count analyzers, has been shown to be a reliable early marker of sepsis. 7 While MDW is also elevated in patients with severe COVID-19, it is not clear if the measure adds any prognostic value beyond the more routinely available NLR. 8 We leveraged retrospective data to assess the additive value of MDW to NLR in predicting the risk of hypoxemic RF in patients with COVID-19 presenting to the emergency department (ED) setting at an academic safety-net healthcare system in Northeast

Ohio. The patient cohort comprised those who visited the ED with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR between 7 days prior to and 5 days after arrival, between May 1, 2020 and February 8, 2021. We excluded patients who arrived as trauma activations, had a charted history of hematologic malignancies and myelodysplastic syndromes, lacked cell count differential data, or had these tests drawn after developing the primary outcome (RF). Hypoxemic RF was defined as the need for mechanical ventilation, high-flow nasal cannula, or nonrebreather, venturi, or simple face mask during the encounter. For each encounter, we collected demographic data, vital signs, and laboratory data. The latter included blood cell count differential data and the MDW measure as reported by the Beckman Coulter DxH 900 analyzer.

Monocyte distribution width and NLR discrimination for hypoxemic RF was computed using area under the curve measures with 95% confidence intervals. Optimal specificity and sensitivity cutoffs for each biomarker were determined using Youden's index. Logistic regressions were developed to predict RF using NLR alone, and then NLR with the addition of MDW. The additive value of MDW to NLR was determined using a likelihood ratio chi-squared test, and the fraction of new information added to the NLR-only model by MDW determined using Harrell's approach. 9 Finally, a Kaplan-Meier curve was constructed to show the value of combining MDW and NLR assessments at our proposed cutoffs on predicting RF. Institutional review board approval was ascertained prior to the initiation of this study. No funding was received for this study. The results of univariate analysis of NLR and the multivariate analysis of NLR in addition to the MDW are shown in Table 1 . The likelihood ratio chi-squared (LR χ 2 ) test comparing these two models demonstrated that the combined NLR plus MDW model was statistically significantly better at predicting hypoxemic failure than NLR alone (LR χ 2 = 20.6, P < .001). The adequacy index calculated from the likelihood ratio chi-squared was 0.56; thus, the fraction of new information from the addition of MDW to NLR was 43.5%. 9 When NLR and MDW were both below their individual Youden's index cutoffs, the negative predictive value for respiratory failure was 96.5%. To further illustrate the value of both measures, a time to event analysis for patients stratified by our derived NLR and MDW threshold values is presented in Figure 1 . Future work on COVID-19-specific risk stratification scoring systems or models should consider inclusion of this measure in addition to more widely available cell population parameters.

Coronavirus, COVID-19, monocyte distribution width, neutrophil-to-lymphocyte ratio, respiratory failure

The authors received no financial support for the research, authorship, and/or publication of this article.

The authors have no competing interests.

The data that support the findings of this study are available from the corresponding author, Yasir Tarabichi, upon reasonable request. 

Estimation of COVID-19-induced depletion of hospital resources in Ontario

A closer look into global hospital beds capacity and resource shortages during the COVID-19 pandemic

Novel coronavirus 2019 (COVID-19): emergence and implications for emergency care

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Predicting poor outcome in patients with suspected COVID-19 presenting to the Emergency Department (COVERED) -development, internal and external validation of a prediction model

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis

Monocyte distribution width: a novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients

Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID-19

Statistically Efficient Ways to Quantify Added Predictive Value of New Measurements. 2020

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients